| Atrial fibrillation ablation using very short duration 50 W ablations and contact force sensing catheters |
22 |
| Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a cross-sectional observational study |
12 |
| Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis |
11 |
| Efficacy of ultrasound-guided axillary/subclavian venous approaches for pacemaker and defibrillator lead implantation: a randomized study |
10 |
| The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: a systematic review |
10 |
| Safety and efficacy of atrial fibrillation ablation guided by Ablation Index module |
10 |
| Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker |
8 |
| Irreversible electroporation for catheter-based cardiac ablation: a systematic review of the preclinical experience |
8 |
| Posterior box isolation as an adjunctive ablation strategy during repeat ablation with the second-generation cryoballoon for recurrence of persistent atrial fibrillation: 1-year follow-up |
8 |
| Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials |
7 |
| High-power, low-flow, short-ablation durationthe key to avoid collateral injury? |
7 |
| Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool |
6 |
| Long-term outcomes following percutaneous left atrial appendage closure in patients with atrial fibrillation and contraindications to anticoagulation |
6 |
| Permanent-temporary pacemakers in the management of patients with conduction abnormalities after transcatheter aortic valve replacement |
6 |
| Predictors of right ventricular pacing and pacemaker dependence in transcatheter aortic valve replacement patients |
5 |
| Predictors of 30-day readmissions after catheter ablation for atrial fibrillation in the USA |
5 |
| Left bundle branch block-induced left ventricular remodeling and its potential for reverse remodeling |
5 |
| N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review |
5 |
| Lesion index: a novel guide in the path of successful pulmonary vein isolation |
5 |
| Long-term outcomes after Zero X-ray arrhythmia ablation |
5 |
| Sex differences in complications of catheter ablation for atrial fibrillation: results on 977 patients |
5 |
| Role of contact force in ischemic scar-related ventricular tachycardia ablation; optimal force required and impact of left ventricular access route |
4 |
| A double-blind, randomised, placebo-controlled, cross-over study assessing the use of XEN-D0103 in patients with paroxysmal atrial fibrillation and implanted pacemakers allowing continuous beat-to-beat monitoring of drug efficacy |
4 |
| Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials |
4 |
| Left atrial voltage mapping: defining and targeting the atrial fibrillation substrate |
4 |
| Mapping and ablation of RVOT-type arrhythmias: comparison between the conventional and reversed U curve methods |
4 |
| Radiotherapy for patients with cardiovascular implantable electronic devices: an 11-year experience |
4 |
| Single 3-min freeze per vein ablation strategy with the second-generation cryoballoon for atrial fibrillation in a large cohort of patients: long term outcome after a single procedure |
4 |
| Predicting factors of transmural thermal injury after cryoballoon pulmonary vein isolation |
4 |
| The benefit of closed loop stimulation in patients with cardioinhibitory vasovagal syncope confirmed by head-up tilt table testing: a systematic review and meta-analysis |
4 |
| Second-generation cryoballoon ablation for recurrent atrial fibrillation after an index cryoballoon procedure: a staged strategy with variable balloon size |
4 |
| Sex effect on efficacy of pulmonary vein cryoablation in patients with atrial fibrillation: data from the multicenter real-world 1STOP project |
4 |
| Bundle branch blocks and/or hemiblocks complicating acute myocardial ischemia or infarction |
4 |
| Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 000 patients |
3 |
| The V-1-V-3 transition index as a novel electrocardiographic criterion for differentiating left from right ventricular outflow tract ventricular arrhythmias |
3 |
| Cardiac automaticity: basic concepts and clinical observations |
3 |
| Intra- and interatrial conduction abnormalities: hemodynamic and arrhythmic significance |
3 |
| The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system |
3 |
| Conscious sedation during subcutaneous implantable cardioverter-defibrillator implantation using the intermuscular technique |
3 |
| Noninvasive tissue adhesive for cardiac implantable electronic device pocket closure: the TAPE pilot study |
3 |
| Efficacy and safety of non-transvenous cardioverter defibrillators in infants and young children |
3 |
| Simultaneous pace-ablate during CARTO-guided pulmonary vein isolation with a contact-force sensing radiofrequency ablation catheter |
3 |
| Acute pericarditis following second-generation cryoballoon ablation for atrial fibrillation |
3 |
| Value of implantable loop recorders in patients with structural or electrical heart disease |
3 |
| Evaluation of the luminal esophageal temperature behavior during left atrium posterior wall ablation by means of second-generation cryoballoon |
3 |
| Efficacy of the optimal ablation index-targeted strategy for pulmonary vein isolation in patients with atrial fibrillation: the OPTIMUM study results |
3 |
| Transvenous cardiac implantable electronic device implantation in patients with persistent left superior vena cava in a tertiary center |
3 |
| The learning curve associated with the implantation of the Nanostim leadless pacemaker |
3 |
| Heart failure as a substrate and trigger for ventricular tachycardia |
3 |
| Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction |
3 |
